Deep Brain Stimulation Compared With Contingency Management for the Treatment of Cocaine Use Disorders: A Threshold and Cost-Effectiveness Analysis.

Fiene Marie Kuijper Uma V MahajanSeul KuDaniel A N BarbosaSheila M AlessiSherman C SteinKyle M KampmanBrandon S BentzleyCasey H Halpern

Published in: Neuromodulation : journal of the International Neuromodulation Society (2021)

We find DBS would not be cost-effective in the short-term (one year) but may be cost-effective in longer timelines. Since DBS holds promise to potentially be a cost-effective treatment for CUDs, future randomized controlled trials should be performed to assess its efficacy.

Keyphrases

deep brain stimulation
parkinson disease
randomized controlled trial
obsessive compulsive disorder
clinical trial
combination therapy
replacement therapy
study protocol